Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2017 12:48 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Fiscal Third Quarter 2017 Financial Results on May 11, 2017

RANCHO CORDOVA, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
May 02, 2017 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca to Exhibit at the 25th International Society for Cellular Therapy (ISCT) Annual Meeting

RANCHO CORDOVA, Calif., May 02, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
April 11, 2017 07:15 ET | Source: Cesca Therapeutics Inc.

CESCA Therapeutics to Present at the 2017 International Symposium of Translational Medicine in Stem Cell Myocardial Repair

RANCHO CORDOVA, Calif., April 11, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
April 07, 2017 15:38 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics’ Management Delivers Keynote Speech at the 2017 Shenzhen International Precision Medicine Summit

RANCHO CORDOVA, Calif., April 07, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
April 03, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Senior Management Promotions

RANCHO CORDOVA, Calif., April 03, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
March 20, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca CLI Feasibility Study Published in Peer-Reviewed Journal

RANCHO CORDOVA, Calif., March 20, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
March 15, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Highlights Promising Data for the Treatment of Chronic Non-Healing Ulcers

RANCHO CORDOVA, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care autologous cell-based therapies,...
March 13, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Closing of $5 Million Revolving Line of Credit

RANCHO CORDOVA, Calif., March 13, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care autologous cell-based therapies,...
February 28, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Strengthens Leadership Team and Board of Directors

Appoints Ms. Vivian Liu as Chief Operating Officer Elects Dr. Russell Medford to its board of directors RANCHO CORDOVA, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc....
February 13, 2017 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update

RANCHO CORDOVA, Calif., Feb. 13, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapies,...